EyeGene Inc. (KOSDAQ:185490)
South Korea
· Delayed Price · Currency is KRW 2,720.00
+210.00 (8.37%)
At close: Mar 28, 2025, 3:30 PM KST
EyeGene Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Operating Revenue | 3,356 | 3,125 | 5,293 | 3,242 | 3,363 | Upgrade
|
Other Revenue | - | -0 | -0 | - | - | Upgrade
|
| Revenue | 3,356 | 3,125 | 5,293 | 3,242 | 3,363 | Upgrade
|
Revenue Growth (YoY) | 7.37% | -40.96% | 63.27% | -3.61% | -20.77% | Upgrade
|
Cost of Revenue | 2,209 | 1,260 | 2,607 | 1,777 | 1,824 | Upgrade
|
Gross Profit | 1,147 | 1,865 | 2,687 | 1,465 | 1,540 | Upgrade
|
Selling, General & Admin | 5,383 | 7,638 | 9,612 | 7,616 | 5,395 | Upgrade
|
Research & Development | 8,266 | 20,363 | 16,343 | 27,994 | 8,823 | Upgrade
|
Other Operating Expenses | 165.23 | 372.49 | 358.84 | 398.58 | 143.12 | Upgrade
|
Operating Expenses | 14,401 | 28,951 | 26,776 | 36,469 | 15,214 | Upgrade
|
Operating Income | -13,254 | -27,086 | -24,089 | -35,004 | -13,675 | Upgrade
|
Interest Expense | -699.01 | -462.6 | -395.32 | -1,754 | -2,517 | Upgrade
|
Interest & Investment Income | 1,468 | 1,891 | 1,579 | 555.89 | 389.95 | Upgrade
|
Earnings From Equity Investments | 10.28 | -168.96 | -23.21 | - | 17.09 | Upgrade
|
Currency Exchange Gain (Loss) | -113.95 | -1.66 | -35.85 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | 223.42 | 5,042 | -4,375 | 1,043 | -729.76 | Upgrade
|
EBT Excluding Unusual Items | -12,365 | -20,786 | -27,340 | -35,159 | -16,515 | Upgrade
|
Gain (Loss) on Sale of Investments | 12.05 | -1,539 | -776.79 | 432.18 | 1,528 | Upgrade
|
Gain (Loss) on Sale of Assets | -543.46 | -30.34 | 1.81 | 44.76 | -0.07 | Upgrade
|
Asset Writedown | - | -78.18 | - | - | - | Upgrade
|
Other Unusual Items | - | 2.69 | 457.29 | 29.38 | -325.85 | Upgrade
|
Pretax Income | -12,896 | -22,430 | -27,657 | -34,653 | -15,313 | Upgrade
|
Income Tax Expense | - | - | -1,168 | -83.99 | -449.93 | Upgrade
|
Earnings From Continuing Operations | -12,896 | -22,430 | -26,489 | -34,569 | -14,863 | Upgrade
|
Minority Interest in Earnings | 768.14 | 1,325 | 536.36 | - | - | Upgrade
|
Net Income | -12,128 | -21,106 | -25,953 | -34,569 | -14,863 | Upgrade
|
Net Income to Common | -12,128 | -21,106 | -25,953 | -34,569 | -14,863 | Upgrade
|
Shares Outstanding (Basic) | 27 | 22 | 21 | 18 | 14 | Upgrade
|
Shares Outstanding (Diluted) | 27 | 22 | 21 | 19 | 14 | Upgrade
|
Shares Change (YoY) | 24.78% | 0.95% | 13.22% | 36.98% | 3.62% | Upgrade
|
EPS (Basic) | -449.00 | -975.00 | -1210.28 | -1970.84 | -1074.88 | Upgrade
|
EPS (Diluted) | -449.00 | -975.00 | -1210.28 | -2053.18 | -1075.00 | Upgrade
|
Free Cash Flow | -13,685 | -21,506 | -19,336 | -32,382 | -11,788 | Upgrade
|
Free Cash Flow Per Share | -506.65 | -993.48 | -901.68 | -1709.67 | -852.51 | Upgrade
|
Gross Margin | 34.18% | 59.69% | 50.76% | 45.19% | 45.77% | Upgrade
|
Operating Margin | -394.95% | -866.63% | -455.07% | -1079.66% | -406.57% | Upgrade
|
Profit Margin | -361.41% | -675.30% | -490.29% | -1066.25% | -441.90% | Upgrade
|
Free Cash Flow Margin | -407.82% | -688.10% | -365.27% | -998.79% | -350.48% | Upgrade
|
EBITDA | -10,910 | -24,949 | -22,798 | -33,934 | -12,821 | Upgrade
|
D&A For EBITDA | 2,343 | 2,137 | 1,291 | 1,070 | 853.25 | Upgrade
|
EBIT | -13,254 | -27,086 | -24,089 | -35,004 | -13,675 | Upgrade
|
Advertising Expenses | 1.89 | 26.52 | 157.83 | 302.3 | 124.12 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.